Analyst John McNulty from BMO Capital maintained a Buy rating on Chemours Company and keeping the price target at $15.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
John McNulty has given his Buy rating due to a combination of factors that highlight Chemours Company’s promising future. One of the key reasons is the recent qualification of Chemours’ two-phase immersion cooling (2PIC) product by Samsung for its latest solid-state storage devices. This endorsement from a major industry player not only validates the technology but also positions Chemours as a leader in the materials space, potentially attracting further interest from other companies.
Additionally, McNulty notes the upcoming commercialization of the 2PIC product, which is on track for 2026, as a significant growth opportunity. Despite the need for EPA approval for sales within the U.S., the ongoing trials and international prospects provide a positive outlook. Furthermore, Chemours is expected to benefit from its other business segments, such as APM and TSS, along with cost-saving measures in the TT business, all contributing to the company’s potential to outperform the market.
In another report released on August 8, RBC Capital also maintained a Buy rating on the stock with a $15.00 price target.
CC’s price has also changed moderately for the past six months – from $17.790 to $14.650, which is a -17.65% drop .